TUVELDRAX Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for TUVELDRAX with the United States Patent and Trademark Office. The USPTO has given the TUVELDRAX trademark a serial number of 79299877. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by Glaxo Group Limited. The TUVELDRAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
tuveldrax

General Information


Serial Number79299877
Word MarkTUVELDRAX
Filing DateWednesday, October 28, 2020
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6422523
Registration DateTuesday, July 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, August 11, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, September 25, 2021NOTIFICATION PROCESSED BY IB
Wednesday, September 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 8, 2021FINAL DISPOSITION PROCESSED
Thursday, August 19, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Monday, May 3, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTICE OF PUBLICATION
Tuesday, March 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Friday, December 25, 2020APPLICATION FILING RECEIPT MAILED
Monday, December 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 18, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB